AIDSVAX

AIDSVAX

AIDSVAX was an experimental HIV vaccine, which was developed and trialed by the VaxGen company. The development and trials of the vaccine received significant coverage in the media, but the trials eventually proved unsuccessful.

AIDSVAX consisted of recombinant gp120, which is a protein unique to HIV's surface. The hope was that six injections of the gp120 protein would stimulate a significant antibody response against the HIV protein, so that when a person was exposed to HIV, their own antibodies would strip the gp120 protein off of the viral particles, effectively disabling the virus so that it could not bind to or invade susceptible cells.

However, the vaccine did not raise particularly high levels of anti-gp120 antibodies in most people, and it was ineffective at preventing infections.


Wikimedia Foundation. 2010.

Игры ⚽ Поможем сделать НИР

Look at other dictionaries:

  • VaxGen — (OTCBB: VXGN) is a biopharmaceutical company based in the San Francisco Bay Area. As of July 28, 2010, VaxGen Inc. was acquired by diaDexus, Inc., in a reverse merger transaction. VaxGen, Inc. does not have significant operations. The company… …   Wikipedia

  • HIV vaccine — An HIV vaccine is a hypothetical vaccine against HIV, the etiological agent of AIDS. As there is no known cure for AIDS, the search for a vaccine has become part of the struggle against the disease.The urgency of the search for a vaccine against… …   Wikipedia

  • HIV — Classification and external resources Diagram of HIV …   Wikipedia

  • Don Francis — Born October 24, 1942 (1942 10 24) (age 69) Bay Area Fields Epidemiology …   Wikipedia

  • HIV-Impfstoff — Der HIV Impfstoff ist ein hypothetischer Impfstoff gegen das Humane Immundefizienz Virus (HIV), den Verursacher der Immunschwächekrankheit AIDS. Für die HIV Infektion gibt es bislang keine Heilungsmöglichkeit, und die Entwicklung einer wirksamen… …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”